The VI All-Russian GMP Conference with International Participation to be held on September 22-24, 2021 in a hybrid format will become one of the key events of the year in the sphere of good practices. This year, the general partner of the Conference is Nacimbio JSC.
The event program is annually developed based on the issues that are vital for representatives of the pharmaceutical industry, which is distinguished by high social significance, scientific content and investment attractiveness.
In recent years, the Russian Federation has paid increased attention to the pharmaceutical industry development, in particular, to construction of high-tech production facilities, which ensure quality and safety of manufactured medicines. The evolution of dialogue and interaction between the state and the industry have become the starting point for developing the Conference plenary session topic “Strong Regulator – Robust Industry.”
The moderators of the plenary session, which will start on September 22, 2021 at 10 a.m., are Dmitry Galkin, Director of the Department for Development of the Pharmaceutical and Medical Industry of the Ministry of Industry and Trade of Russia, and Vladislav Shestakov, Director of FSI “State Institute of Drugs and Good Practices” under the Ministry of Industry and Trade of Russia.
At the session, it is planned to analyze the actions and decisions taken by regulators and participants of the market during the pandemic, to evaluate their results, to share the experience of interdepartmental interaction and international cooperation.
Representatives of the Ministry of Industry and Trade of Russia, the Ministry of Health of Russia, Federal Service for the Supervision of Public Health and Social Development, regulators of the Eurasian Economic Union member countries and other foreign regulatory bodies, pharmaceutical companies and industry associations are invited to participate in the session.
Participation of specialists of the Delegation of the European Union to the Russian Federation, the African Union on issues relating to African Medicines Agency (AMA), Cuban Center for State Control of Medicines, Medical Equipment and Devices, Bangladesh General Directorate of Drug Administration (DGDA), Australian Therapeutic Goods Administration (TGA), Algerian National Agency of Pharmaceutical Products is expected.
Nowadays, the regulatory framework in the field of medicines development, manufacture and circulation is being improved and is distinguished by a commitment to harmonization of supranational legislation and development of uniform rules and approaches. As part of these processes, measures are being implemented to preserve human health and ensure access to safe, high-quality and efficient medicines for the maximum possible amount of people living in the world.
To learn more about participation in the VI All-Russian GMP Conference with International Participation and the program, visit the website: www.gosgmp.ru